CRC applies a broad range of proprietary technologies, including sophisticated neuropsychological assessment and state-of-the-art
simulation technologies in a broad range of studies with objectives that include:
Assessing the therapeutic value of products developed to treat a wide range of disorders, particularly those that affect
Assessing the effects of the full range of drugs and treatments for medical and psychiatric disorders on cognition, motoric
abilities, wakefulness and mood; and
Developing treatments and strategies to maintain and enhance cognitive performance diminished by age, fatigue, trauma or disease.